| (3-(6H-dibenzo[c,f]oxepin-11-ylidene)propyl)dimethylamine, chloride |
| (3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethyl-1-propanamine hydrochloride |
| (3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethyl-propan-1-amine hydrochloride |
| (3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine hydrochloride |
| (3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine;hydrochloride |
| (3Z)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine hydrochloride |
| (e)-doxepin hydrochloride |
| (Z)-Doxepin hydrochloride |
| (Z)-N,N-Dimethyldibenz(b,e)oxepin-delta(sup 11(6H),gamma)-propylamine hydrochloride |
| 1-Propanamine, 3-dibenz(b,e)oxepin-11-(6H)-ylidene-N,N-dimethyl-dimethyl-, hydrochloride, (E)- |
| 1-Propanamine, 3-dibenz(b,e)oxepin-11(6H)-ylidene-N,N-dimethyl-, hydrochloride, (Z)- |
| 1-Propanamine, 3-dibenz(b,e)oxepin-11(6H)ylidene-N,N-dimethyl-, hydrochloride |
| 1-Propanamine, 3-dibez[b,e]oxepin-11(6H)-ylidene-N,N-dimethyl-, hydrochloride |
| 1-Propanamine,e]oxepin-11(6H)-ylidene-N,N-dimethyl-, hydrochloride |
| 1-Propanamine,e]oxepin-11(6H)ylidene-N,N-dimethyl-, hydrochloride |
| 11-(3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin hydrochloride |
| 11-(3-Dimethylaminopropylidene)-6,11-dihydro-benz[b,e]Oxepin |
| 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin hydrochloride |
| 11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepine hydrochloride |
| 11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenzo[b,e]oxepine Hydrochloride |
| 11-(Dimethylamino)propylidene 6H-dibenz[b,e]oxepin |
| 11-dimethylaminopropylidene6h-dibenz(b,e)oxepin |
| 11[16h]-[3-(dimethylamino)-propylidene]dibenz[b,e]oxepine hydrochloride |
| 1229-29-4 |
| 20917-44-6 |
| 229D294 |
| 25127-31-5 |
| 25197-84-6 |
| 3-Dibenz(b,c)oxepin 11(6H)ylidene-N,N-dimethyl-1-propanamine |
| 3-dibenz(b,c)oxepin 11(6h)ylidene-n,n-dimethyl-1-propanamine hydrochloride |
| 4698-39-9 |
| A804993 |
| AB0109368 |
| AC-8076 |
| AC1NQY0E |
| AC1O4WGB |
| Adapin |
| AKOS015895087 |
| AKOS024458484 |
| API0002487 |
| Aponal |
| AS-13316 |
| BG0175 |
| C-19460 |
| C19H21NO.HCl |
| CAS-1229-29-4 |
| CCG-220263 |
| CCG-221643 |
| CCG-38932 |
| CHEBI:4711 |
| CHEMBL1200462 |
| CHEMBL1256774 |
| Cidoxepin HCl |
| Cidoxepin hydrochloride |
| Cidoxepin hydrochloride (USAN) |
| Cidoxepin hydrochloride [USAN] |
| cis-Doxepin hydrochloride |
| CPD000058230 |
| CPD000449270 |
| CS-2972 |
| CU61C5RH24 |
| Curatin |
| D 4526 |
| D00814 |
| D03491 |
| D4626 |
| Dibenz(b,e)oxepin-delta(sup 11(6H),gamma)-propylamine, N,N-dimethyl-, hydrochloride |
| Dibenz(b,e)oxepin-delta11(6H),gamma-propylamine, N,N-dimethyl-, hydrochloride |
| Dibenz(b,e)oxepin-delta11(6H),gamma-propylamine, N,N-dimethyl-, hydrochloride (8CI) |
| Dibenz[b,.gamma.-propylamine, N,N-dimethyl-, hydrochloride |
| Dibenz[b,.gamma.)-propylamine, N,N-dimethyl-, hydrochloride |
| dimethyl(3-{9-oxatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene}propyl)amine hydrochloride |
| Doxepin (Hydrochloride) |
| Doxepin (Z)-isomer hydrochloride |
| Doxepin cis-form hydrochloride |
| Doxepin for system suitability, European Pharmacopoeia (EP) Reference Standard |
| Doxepin HCl |
| Doxepin hydrochlorid |
| Doxepin Hydrochloride |
| Doxepin hydrochloride (E)-isomer |
| Doxepin hydrochloride (USP) |
| Doxepin hydrochloride [USAN:USP] |
| Doxepin Hydrochloride [USAN] |
| Doxepin Hydrochloride 1.0 mg/ml in Methanol (as free base) |
| Doxepin hydrochloride, ~85% E-isomer basis, >=98% (GC), 15% Z-isomer basis, powder |
| Doxepin hydrochloride, European Pharmacopoeia (EP) Reference Standard |
| Doxepin hydrochloride, United States Pharmacopeia (USP) Reference Standard |
| Doxepine hydrochloride |
| DSSTox_CID_25145 |
| DSSTox_GSID_45145 |
| DSSTox_RID_80701 |
| DTXSID8045145 |
| EINECS 214-966-8 |
| EU-0100339 |
| H882 |
| HMS1568F08 |
| HMS1920I22 |
| HY-B0725 |
| I06-0502 |
| J10288 |
| Jsp001539 |
| KS-5094 |
| LP00339 |
| LS-61639 |
| MF 10 HCl |
| MFCD00079135 |
| MLS000069794 |
| MLS000758259 |
| MLS001148235 |
| MLS001423974 |
| MLS002207250 |
| MLS002222181 |
| MLS002548858 |
| MolPort-003-666-170 |
| MolPort-003-872-120 |
| N,e]oxepin-.delta. (sup11(6H),.gamma.)-propylamine hydrochloride |
| N,e]oxepin-.delta.-11(6H).gamma.-propylamine HCl |
| N,e]oxepin-.DELTA.11(6H),.gamma.-propylamine hydrochloride |
| N,e]oxepin-.DELTA.11(6H),.gamma.-propylamine, hydrochloride |
| N,N-Dimethyldibenz(b,e)oxepin-delta(sup 11(6H),gamma)-propylamine hydrochloride |
| NC00052 |
| NC00447 |
| NCGC00015344-03 |
| NCGC00024623-04 |
| NCGC00093778-01 |
| NCGC00093778-02 |
| NCGC00094661-01 |
| NCGC00094661-02 |
| NCGC00261024-01 |
| Novoxapin |
| Novoxapin hydrochloride |
| NSC-108160 |
| NSC-756750 |
| NSC108160 |
| NSC756750 |
| Opera_ID_675 |
| P 4599 |
| P-3693A |
| P-4599 |
| Pharmakon1600-01500264 |
| Prestwick_187 |
| Q-201044 |
| SAM001246976 |
| SAM002264608 |
| SBB005916 |
| SC-62324 |
| SCHEMBL124597 |
| SCHEMBL60287 |
| Sinequan |
| Sinequin |
| SMR000058230 |
| SMR000449270 |
| SPECTRUM1500264 |
| SR-01000075551 |
| SR-01000075551-1 |
| ST025239 |
| timtec-bb sbb005916 |
| Toruan |
| Tox21_110130 |
| Tox21_110130_1 |
| Tox21_500339 |
| trans-Doxepin hydrochloride |
| UNII-3U9A0FE9N5 component MHNSPTUQQIYJOT-CULRIWENSA-N |
| UNII-3U9A0FE9N5 component MHNSPTUQQIYJOT-SJDTYFKWSA-N |
| UNII-CU61C5RH24 |
| UNII-XI27WMG8QK |
| WLN: T C676 IO&T&J B3N1&1 &GH |
| XI27WMG8QK |
| Zonalon |
| Zonalon (TN) |
